Gene · 10499
Papers3,077
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,077
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma. | Br J Cancer | 2023 | 37076565 | PubTator, text mining | PubMed |
| ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems. | Commun Biol | 2023 | 37059746 | PubTator, text mining | PubMed |
| DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy. | Clin Cancer Res | 2023 | 37058257 | PubTator, text mining | PubMed |
| Efficacy and safety of Jinhua Qinggan granules in the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. | Medicine (Baltimore) | 2023 | 37058020 | PubTator, text mining | PubMed |
| Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma-diagnostic challenge and report of two cases. | Genes Chromosomes Cancer | 2023 | 37057803 | PubTator, text mining | PubMed |
| A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer. | Int J Mol Sci | 2023 | 37047814 | PubTator, text mining | PubMed |
| The efficacy and potential mechanism of Danggui Buxue Decoction in treating diabetic nephropathy: A meta-analysis and network pharmacology. | Medicine (Baltimore) | 2023 | 37026924 | PubTator, text mining | PubMed |
| Indeterminate cell histiocytosis: A systematic review of the literature with a comprehensive revision of clinical, histopathological, and molecular features. | J Eur Acad Dermatol Venereol | 2023 | 37016977 | PubTator, text mining | PubMed |
| What's new in bone and soft tissue pathology 2023: guidelines for molecular testing. | J Pathol Transl Med | 2023 | 37015324 | PubTator, text mining | PubMed |
| Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS). | Ther Adv Med Oncol | 2023 | 37007636 | PubTator, text mining | PubMed |
| Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis. | Diagn Pathol | 2023 | 36998041 | PubTator, text mining | PubMed |
| The Recent Advances in Molecular Diagnosis of Soft Tissue Tumors. | Int J Mol Sci | 2023 | 36983010 | PubTator, text mining | PubMed |
| Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts-A Systematic Review. | Cancers (Basel) | 2023 | 36980718 | PubTator, text mining | PubMed |
| Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings. | Cancers (Basel) | 2023 | 36980590 | PubTator, text mining | PubMed |
| Biological Role and Clinical Implications of MYOD1L122R Mutation in Rhabdomyosarcoma. | Cancers (Basel) | 2023 | 36980529 | PubTator, text mining | PubMed |
| Significant Association of Estrogen Receptor-β Isoforms and Coactivators in Breast Cancer Subtypes. | Curr Issues Mol Biol | 2023 | 36975536 | PubTator, text mining | PubMed |
| [Ependymoma-like tumor with mesenchymal differentiation harboring ZFTA-NCOA1/2 fusion: clinical, histological and immunophenotypical characteristics]. | Zhonghua Bing Li Xue Za Zhi | 2023 | 36973203 | PubTator, text mining | PubMed |
| NCOA2-induced secretion of leptin leads to fetal growth restriction via the NF-κB signaling pathway. | Ann Transl Med | 2023 | 36923094 | PubTator, text mining | PubMed |
| RNF213 modulates γ-herpesvirus infection and reactivation via targeting the viral Replication and Transcription Activator. | Proc Natl Acad Sci U S A | 2023 | 36917666 | PubTator, text mining | PubMed |
| Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study. | Neuro Oncol | 2023 | 36916248 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10499/papers?page=13